<?xml version='1.0' encoding='utf-8'?>
<document id="29352982"><sentence text="Inhibition of CYP3A by Antimalarial Piperaquine and Its Metabolites in Human Liver Microsomes With IVIV Extrapolation."><entity charOffset="36-47" id="DDI-PubMed.29352982.s1.e0" text="Piperaquine" /></sentence><sentence text="The potential of the antimalarial piperaquine and its metabolites to inhibit CYP3A was investigated in pooled human liver microsomes"><entity charOffset="34-45" id="DDI-PubMed.29352982.s2.e0" text="piperaquine" /></sentence><sentence text=" CYP3A activity was measured by liquid chromatography-tandem mass spectrometry as the rate of 1'-hydroxymidazolam formation"><entity charOffset="94-113" id="DDI-PubMed.29352982.s3.e0" text="1'-hydroxymidazolam" /></sentence><sentence text=" Piperaquine was found to be a reversible, potent inhibitor of CYP3A with the following parameter estimates (%CV): IC50 = 0"><entity charOffset="1-12" id="DDI-PubMed.29352982.s4.e0" text="Piperaquine" /></sentence><sentence text="76 μM (29), Ki = 0" /><sentence text="68 μM (29)" /><sentence text=" In addition, piperaquine acted as a time-dependent inhibitor with IC50 declining to 0"><entity charOffset="14-25" id="DDI-PubMed.29352982.s7.e0" text="piperaquine" /></sentence><sentence text="32 μM (28) during 30-min pre-incubation" /><sentence text=" Time-dependent inhibitor estimates were kinact = 0" /><sentence text="024 min-1 (30) and KI = 1" /><sentence text="63 μM (17)" /><sentence text=" Metabolite M2 was a highly potent reversible inhibitor with estimated IC50 and Ki values of 0" /><sentence text="057 μM (17) and 0" /><sentence text="043 μM (3), respectively" /><sentence text=" M1 and M5 metabolites did not show any inhibitory properties within the limits of assay used" /><sentence text=" Average (95th percentile) simulated in vivo areas under the curve of midazolam increased 2" /><sentence text="2-fold (3" /><sentence text="7-fold) on the third which is the last day of piperaquine dosing, whereas for its metabolite M2, areas under the curve of midazolam increased 7"><entity charOffset="46-57" id="DDI-PubMed.29352982.s18.e0" text="piperaquine" /></sentence><sentence text="7-fold (13-fold)" /><sentence text="" /></document>